Piper Sandler analyst Yasmeen Rahimi downgraded Korro Bio (KRRO) to Neutral from Overweight with a price target of $11, down from $180.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KRRO:
- Korro Bio downgraded to Neutral from Buy at H.C. Wainwright
- Korro Bio downgraded to Sector Perform from Outperform at RBC Capital
- Korro Bio downgraded to Market Perform from Outperform at William Blair
- Korro Bio downgraded to Neutral from Overweight at Cantor Fitzgerald
- Korro Bio downgraded to Market Perform from Strong Buy at Raymond James